Celldex Therapeutics, Inc. (CLDX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
Source: SeekingAlpha
2025-09-10 12:20:09 ET
Celldex Therapeutics, Inc. (CLDX) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 3:20 PM EDT...
Read the full article on Seeking Alpha
For further details see:
Celldex Therapeutics, Inc. (CLDX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
Celldex Therapeutics Inc.
NASDAQ: CLDX
CLDX Trading
5.31% G/L:
$30.445 Last:
591,333 Volume:
$29.21 Open:
CLDX Latest News
February 27, 2026 02:45:00 pm
Celldex Presents Additional Positive Data from Phase 2 Chronic Spontaneous Urticaria (CSU) and Phase 2 Cold Urticaria (ColdU) and Symptomatic Dermographism (SD) Studies Further Demonstrating First-in-Class and Best-in-Disease Barzolvolimab Profile at AAAA
February 25, 2026 04:01:00 pm
Celldex Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update
CLDX Stock Data
$1,661,236,775
63,525,694
0.16%
57
N/A
Biotechnology & Life Sciences
Healthcare
US
Hampton
